[HTML][HTML] Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
…, S Yalavarthi, V Betin, T Natoli, S Navaz… - Nature …, 2023 - nature.com
While immunologic correlates of COVID-19 have been widely reported, their associations
with post-acute sequelae of COVID-19 (PASC) remain less clear. Due to the wide array of …
with post-acute sequelae of COVID-19 (PASC) remain less clear. Due to the wide array of …
[HTML][HTML] Autoantibodies stabilize neutrophil extracellular traps in COVID-19
Y Zuo, S Yalavarthi, SA Navaz, CK Hoy, A Harbaugh… - JCI insight, 2021 - ncbi.nlm.nih.gov
The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is
recognized to play an important role in the thromboinflammatory milieu inherent to severe …
recognized to play an important role in the thromboinflammatory milieu inherent to severe …
[HTML][HTML] Endothelial cell–activating antibodies in COVID‐19
H Shi, Y Zuo, S Navaz, A Harbaugh… - Arthritis & …, 2022 - Wiley Online Library
Objective While endothelial dysfunction has been implicated in the widespread thromboinflammatory
complications of COVID‐19, the upstream mediators of endotheliopathy remain, for …
complications of COVID‐19, the upstream mediators of endotheliopathy remain, for …
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials …
Y Zuo, S Navaz, A Tsodikov, K Kmetova… - Arthritis & …, 2023 - Wiley Online Library
Objective This study aimed to elucidate the presence, antigen specificities, and potential clinical
associations of anti–neutrophil extracellular trap (anti‐NET) antibodies in a multinational …
associations of anti–neutrophil extracellular trap (anti‐NET) antibodies in a multinational …
Prevalence of antiphospholipid antibodies and association with incident cardiovascular events
Importance The prevalence of antiphospholipid antibodies (aPL) and their association with
future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly …
future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly …
[HTML][HTML] Circulating calprotectin as a predictive and severity biomarker in patients with COVID-19
GL Norman, SA Navaz, Y Kanthi, R Albesa, M Mahler… - Diagnostics, 2022 - mdpi.com
Background: New tools for the assessment and prediction of the severity of hospitalized
COVID-19 patients can help direct limited resources to patients with the greatest need. …
COVID-19 patients can help direct limited resources to patients with the greatest need. …
Calprotectin impairs platelet survival in patients with primary antiphospholipid syndrome
CK Hoy, SK NaveenKumar, SA Navaz… - Arthritis & …, 2024 - Wiley Online Library
Objective While thrombosis and pregnancy loss are the best‐known clinical features of
antiphospholipid syndrome (APS), many patients also exhibit “extra‐criteria” manifestations, like …
antiphospholipid syndrome (APS), many patients also exhibit “extra‐criteria” manifestations, like …
Anti-NET antibodies in antiphospholipid antibody-positive patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal …
Y Zuo, S Navaz, A Tsodikov, K Kmetova… - Arthritis & …, 2023 - europepmc.org
Objective Our study aimed to elucidate the presence, antigen specificities, and potential
clinical association of anti-neutrophil extracellular trap (anti-NET) antibodies in a multinational …
clinical association of anti-neutrophil extracellular trap (anti-NET) antibodies in a multinational …
Autoantibodies stabilize neutrophil extracellular traps in COVID-19 (preprint)
Y Zuo, S Yalavarthi, S Navaz, C Hoy, A Harbaugh… - 2021 - pesquisa.bvsalud.org
The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is
recognized to play an important role in the thromboinflammatory milieu inherent to severe …
recognized to play an important role in the thromboinflammatory milieu inherent to severe …
[CITATION][C] Circulating Calprotectin: A Potential New Biomarker for" Non-Criteria
C Hoy, NSK Kumar, S Navaz… - ARTHRITIS & …, 2022 - … ST, HOBOKEN 07030-5774, NJ USA
